Aurinia Pharmaceuticals Inc (AUPH)
8.12
-0.21
(-2.52%)
USD |
NASDAQ |
Nov 15, 16:00
8.125
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Free Cash Flow (Quarterly): 16.90M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 16.90M |
| June 30, 2024 | 15.76M |
| March 31, 2024 | -18.61M |
| December 31, 2023 | 14.25M |
| September 30, 2023 | -13.20M |
| June 30, 2023 | -3.053M |
| March 31, 2023 | -32.18M |
| December 31, 2022 | 10.32M |
| September 30, 2022 | -15.40M |
| June 30, 2022 | -27.91M |
| March 31, 2022 | -46.82M |
| December 31, 2021 | -26.22M |
| September 30, 2021 | -40.41M |
| June 30, 2021 | -37.84M |
| March 31, 2021 | -54.72M |
| December 31, 2020 | 1.021M |
| September 30, 2020 | -32.70M |
| June 30, 2020 | -22.71M |
| March 31, 2020 | -22.82M |
| December 31, 2019 | -25.44M |
| September 30, 2019 | -11.80M |
| June 30, 2019 | -13.28M |
| March 31, 2019 | -13.17M |
| December 31, 2018 | -13.64M |
| September 30, 2018 | -11.33M |
| Date | Value |
|---|---|
| June 30, 2018 | -12.32M |
| March 31, 2018 | -14.40M |
| December 31, 2017 | -8.94M |
| September 30, 2017 | -8.525M |
| June 30, 2017 | -14.01M |
| March 31, 2017 | -9.719M |
| December 31, 2016 | -4.277M |
| September 30, 2016 | -4.192M |
| June 30, 2016 | -5.048M |
| March 31, 2016 | -5.221M |
| December 31, 2015 | -4.838M |
| September 30, 2015 | -5.227M |
| June 30, 2015 | -3.719M |
| March 31, 2015 | -4.032M |
| December 31, 2014 | -3.369M |
| September 30, 2014 | -4.045M |
| June 30, 2014 | -4.229M |
| March 31, 2014 | -5.355M |
| December 31, 2013 | -2.572M |
| September 30, 2013 | -1.521M |
| June 30, 2013 | -0.428M |
| March 31, 2013 | -0.207M |
| December 31, 2012 | -0.7887M |
| September 30, 2012 | -1.255M |
| June 30, 2012 | -2.722M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-54.72M
Minimum
Mar 2021
16.90M
Maximum
Sep 2024
-18.09M
Average
-22.76M
Median
Free Cash Flow (Quarterly) Benchmarks
| Edesa Biotech Inc | -0.8565M |
| Lexaria Bioscience Corp | -1.288M |
| Xenon Pharmaceuticals Inc | -34.19M |
| ESSA Pharma Inc | -5.745M |
| ImmunoPrecise Antibodies Ltd | -1.524M |